Tradestie Institutional Equity Comparison Engine
AKTX vs GNMX โ Head-to-Head Terminal
6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.
Pillar 1 Executive Scorecard & Category Winner Tally
AKTX Overall Edge
AKTX Captures Institutional Edge (2โ0 Pillars ยท 5โ3 Matrix Metrics)
Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Akari Therapeutics plc ADR (0.01 USD) (AKTX) driven by superior Growth & Margin, Momentum & Technical. Fundamentally, AKTX trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus GNMX at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, AKTX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against GNMX sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).
Valuation Winner
Tie
AKTX N/M vs GNMX N/M Fwd P/E
Growth & Margin Winner
AKTX
Op Margin 0.0% vs N/A ยท YoY +0.0% vs N/A
Momentum & Technical Winner
AKTX
1Y +1339.7% vs +24.7% ยท 52W Pos 24% vs 51%
Options & Structure Winner
Tie
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (N/A IV)
AKTX
NASDAQ
Akari Therapeutics plc ADR (0.01 USD)
Pharmaceutical Preparations
$7.18
+7.0% 1D
Market Cap
$15.6M
1M Return
-11.36%
1Y Return
+1339.74%
Forward P/E
N/M
Unified AI Score
50.1 / 100
HOLD
Tech 65.0
Fund 56.0
Flow 50.0
Mom 50.0
GNMX
US Equity
GNMX
Institutional Equity
$32.06
-3.04% 1D
Market Cap
N/A
1M Return
-12.19%
1Y Return
+24.73%
Forward P/E
N/M
Unified AI Score
53.1 / 100
HOLD
Tech 25.0
Fund 48.0
Flow 50.0
Mom 70.0
Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)
1Y Indexed Return:
AKTX +1339.74%
GNMX +24.73%
Spread: +1.36 pp (GNMX Lead)
Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)
AKTX TTM Op. Margin: 0.0%
GNMX TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on AKTX vs GNMX. Trailing 12-month operating profitability (AKTX 0.0% vs GNMX N/A) and valuation multiples (AKTX N/M vs GNMX N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Pillar 4 Head-to-Head Fundamental & Valuation Matrix
| Institutional Metric | AKTX | GNMX | Criterion | Row Winner |
|---|---|---|---|---|
| Market Capitalization Scale | $15.6M | N/A | Larger Scale | AKTX |
| Trailing P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Forward P/E Ratio Valuation | N/M | N/M | Lower Multiple | Tie |
| Revenue Growth (YoY) Growth | +0.0% | N/A | Higher Growth | AKTX |
| Operating Margin (TTM) Profitability | 0.0% | N/A | Higher Margin | AKTX |
| Net Profit Margin Profitability | 0.0% | N/A | Higher Margin | AKTX |
| Return on Equity (ROE) Capital Efficiency | -146.3% | N/A | Higher ROE | AKTX |
| 52-Week Range Position Momentum | 24% ($0โ$29) | 51% ($24โ$40) | Stronger Trend | GNMX |
| Beta / 30D Volatility Risk Regime | 77.35ฮฒ ยท 143% Vol | 1.19ฮฒ ยท 44% Vol | Lower Realized Risk | GNMX |
| Unified Institutional Score Composite Signal | 50.1 / 100 (HOLD) | 53.1 / 100 (HOLD) | Higher Composite | GNMX |
Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor
Full AKTX vs GNMX Buy Guide
AKTX
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
GNMX
UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
IV Percentile
N/A
IV Regime
Unclassified
Pillar 6 90-Day Technical & R&D Innovation Disclosures
Corporate R&D & Foundry Tracker
Neither AKTX nor GNMX registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.